PAION initiated a dedicated safety study of Remimazolam in American Society of Anesthesiologists classification III to IV patients undergoing colonoscopy as part of the U.S. Phase III program.
EndoGastric Solutions secured additional financing of up to $50 million.
Olympus launched EZDilate multi-stage endoscopic balloon dilator.
More articles on GI/endoscopy:
CMS bumps up payments for incomplete colonoscopies: 3 key points
New PAION study focuses on use of Remimazolam in high-risk colonoscopy patients: 4 things to know
GI physician leader to know: Dr. Kalpesh Thakkar of Memorial Hermann Medical Group
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.